Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Gevokizumab

EU orphan designation number: EU/3/13/1111   
Active ingredient: Gevokizumab
Indication: Treatment of chronic non-infectious uveitis
Sponsor: Les Laboratoires Servier
50 rue Carnot, F-92284 Suresnes CEDEX, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2013 Centralised Orphan - Designation EMA/OD/161/12 (2013)1604 of 12/03/2013